19.58
0.00
(0.00%)
At close: 5:29:45 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -22.39 | -22.8 |
| Low Estimate | 0 | 0 | -22.39 | -22.8 |
| High Estimate | 0 | 0 | -22.39 | -22.8 |
| Year Ago EPS | -- | -- | -21.54 | -22.39 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 8M | 8M |
| Low Estimate | -- | -- | 8M | 8M |
| High Estimate | -- | -- | 8M | 8M |
| Year Ago Sales | -- | -- | 7.83M | 8M |
| Sales Growth (year/est) | -- | -- | 2.24% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -22.39 | -22.8 |
| 7 Days Ago | 0 | 0 | -22.39 | -22.8 |
| 30 Days Ago | 0 | 0 | -22.39 | -22.8 |
| 60 Days Ago | 0 | 0 | -22.39 | -22.8 |
| 90 Days Ago | 0 | 0 | -22.39 | -22.8 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EXPRS2.ST | -- | -- | -3.94% | -1.86% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Related Tickers
FLUO.ST FluoGuide A/S
40.90
+11.44%
ONCO.ST Oncopeptides AB (publ)
1.9540
-2.01%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1240
+4.64%
SANION.ST Saniona AB (publ)
6.72
-0.59%
BAVA.CO Bavarian Nordic A/S
145.85
+0.24%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1970
+8.00%
HNSA.ST Hansa Biopharma AB (publ)
21.88
-1.08%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
DBP-B.ST Double Bond Pharmaceutical Int.
0.3170
-5.93%
24H.F Hansa Biopharma AB (publ)
1.8980
-2.57%